Search

Arnold B Rabson

from Princeton, NJ
Age ~68

Arnold Rabson Phones & Addresses

  • 59 Marion Rd, Princeton, NJ 08540 (609) 334-9116
  • Trenton, NJ
  • Silver Spring, MD
  • Bethesda, MD
  • Newark, NJ
  • 59 Marion Rd E, Princeton, NJ 08540

Education

School / High School: Brown University / Alpert Medical School 1980

Languages

English

Specialities

Other

Professional Records

Medicine Doctors

Arnold Rabson Photo 1

Arnold B Rabson, New Brunswick NJ

View page
Specialties:
Other
Address:
89 French St, New Brunswick, NJ 08901
Languages:
English
Education:
Medical School
Brown University / Alpert Medical School
Graduated: 1980
Arnold Rabson Photo 2

Arnold Rabson, New Brunswick NJ

Work:
The Cancer Institute Of Nj
195 Little Albany St, New Brunswick, NJ 08901

Business Records

Name / Title
Company / Classification
Phones & Addresses
Arnold Bernard Rabson
Arnold Rabson MD
Genetic Medicine · Internist
89 French St, New Brunswick, NJ 08901
Arnold Rabson
Deputy Director
University of Medicine and Dentistry of Nj (Inc)
College/University Administrative Educational Programs · University · Health Clinic · College/University · Colleges, Universities, and Pr
65 Bergen St, Newark, NJ 07107
PO Box 542, Newark, NJ 07101
150 Bergen St STE 1, Newark, NJ 07103
90 Bergen St STE 4500, Newark, NJ 07103
(973) 972-4400, (973) 972-6456, (973) 972-8504, (973) 972-5410

Publications

Us Patents

Hiv-1 Vectors

View page
US Patent:
58375120, Nov 17, 1998
Filed:
Dec 14, 1995
Appl. No.:
8/574586
Inventors:
Arnold B. Rabson - Princeton NJ
Hsin-Ching Lin - Edison NJ
Marion Bodkin - Massapequa NY
Roger Strair - Skillman NJ
Assignee:
University of Medicine & Dentistry of NJ - Newark NJ
International Classification:
C12N 1586
C12N 510
C12N 1564
C12N 1549
US Classification:
4351723
Abstract:
The present invention pertains to a genetically altered human immunodeficiency virus type 1 (HIV-1) which replicates only in human CD4+ cells that express the Tax protein of Human T-cell Lymphotropic Virus Type I (HTLV-I), wherein the HIV long terminal repeat (LTR) promoter and enhancer sequences (NF-kappa-B and Sp1 binding sites) of the genetically altered human immunodeficiency virus type 1 have been replaced by two copies of the HTLV-I LTR 21 base pair repeat Tax-responsive element (TRE). The present invention also pertains to methods for killing HTLV-1 infected cells in humans with HTLV-1 disease (HTLV-1 tumors and HAM/TSP) with the novel genetically altered human immunodeficiency virus type 1 (HIV-1).
Arnold B Rabson from Princeton, NJ, age ~68 Get Report